Management of burn injuries – recent developments in resuscitation, infection control and outcomes research by Dries, David J
BioMed  Central
Page 1 of 13
(page number not for citation purposes)
Scandinavian Journal of Trauma, 
Resuscitation and Emergency Medicine
Open Access Commentary
Management of burn injuries – recent developments in 
resuscitation, infection control and outcomes research
David J Dries1,2
Address: 1Regions Hospital, Department of Surgery, 640 Jackson Street, St. Paul, MN 55101, USA and 2University of Minnesota, Department of 
Surgery, 420 Delaware Street S, Minneapolis, MN 55455, USA
Email: David J Dries - david.j.dries@healthpartners.com
Abstract
Introduction: Burn injury and its subsequent multisystem effects are commonly encountered by
acute care practitioners. Resuscitation is the major component of initial burn care and must be
managed to restore and preserve remote organ function. Later complications of burn injury are
dominated by infection. Burn centers are often called to manage soft tissue problems outside
thermal injury including soft tissue infection and Toxic Epidermal Necrolysis.
Methods: A selected review of recent reports published by the American Burn Association is
provided.
Results: The burn-injured patient is easily and frequently over resuscitated with complications
including delayed wound healing and respiratory compromise. A feedback protocol is designed to
limit the occurrence of excessive resuscitation has been proposed but no new "gold standard" for
resuscitation has replaced the Parkland formula. Significant additional work has been included in
recent guidelines identifying specific infectious complications and criteria for these diagnoses in the
burn-injured patient. While new medical therapies have been proposed for patients sustaining
inhalation injury, a new standard of medical therapy has not emerged. Renal failure as a contributor
to adverse outcome in burns has been reinforced by recent data generated in Scandinavia. Of
special problems addressed in burn centers, soft tissue infections and Toxic Epidermal Necrolysis
have been reviewed but new treatment strategies have not been identified. The value of burn
centers in management of burns and other soft tissue problems is supported in several recent
reports.
Conclusion: Recent reports emphasize the dangers of over resuscitation in the setting of burn
injury. No new medical therapy for inhalation injury exists but new standards for description of
burn-related infections have been presented. The value of the burn center in care of soft tissue
problems including Toxic Epidermal Necrolysis and soft tissue infections is supported in recent
papers.
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Introduction
The burn-injured patient is unique in resuscitation
requirements, metabolic stress, pattern of complications
and determinants of outcome.[1] This review highlights a
selected group of papers focused on those aspects of care
which are unique to burn centers and the burn-injured
patient and contribute in important ways to outcome.
Contemporary discussion of burn resuscitation features
the Parkland formula proposed by Baxter and coworkers
in the 1960s.[2] Reviews of recent experience with burn
resuscitation suggest that treatment objectives and fluids
administered in the approach recommended by the Park-
land group are frequently exceeded.[3] What is contempo-
rary thinking about initial fluid administration in the
setting of burn injury? The American Burn Association
(ABA) has recently presented a statement which begins to
answer this question.[4] The Parkland Burn Center
recently published a report on the use of the Parkland for-
mula in the institution where it originated.[5] Sepsis also
presents in non-traditional ways in the burn-injured
patient.[1] I have summarized, for the non-burn physi-
cian and surgeon some of the key aspects of a recent con-
sensus statement produced by the American Burn
Association  about organ-specific septic complications in
the setting of burn injury.
A number of outcome indicators related to burn unit prac-
tice are coming into clearer focus. Several papers summa-
rize this recent thinking and are reviewed here. First, renal
failure has an incremental impact of mortality in any crit-
ical care unit population.[6] We now have data to suggest
that similar concerns are true in burns. Burn units are
often the site for management of soft tissue problems not
specifically associated with extremes of temperature. The
two most common problems of this type seen in burn
practice are Toxic Epidermal Necrolysis (TEN) and soft tis-
sue infections.[7,8] Both of these problems require the
wound care expertise of burn unit personnel. Because
these problems are relatively infrequent, outcome data
related to Toxic Epidermal Necrolysis and soft tissue infec-
tion are hard to find or available only in early reports.[7,9]
Recent papers attempt to bring outcomes of these impor-
tant but infrequent problems into focus. The impact of
burn verification on comparative outcomes in a geo-
graphic region is also reviewed.[10]
Finally, Western nations face an obesity epidemic.[11]
The impact of obesity on functional outcome in burns has
been compared to other complications. Recent reports
shed light on this issue and are reviewed below.
Materials and methods
This is a selected review of recent literature and summary
statements of the American Burn Association provided for
the physician or surgeon with an interest in injury who is
not a regular burn unit practitioner or burn specialist.
These papers are selected to provide an update summariz-
ing key points in these recent reports.
Resuscitation
Fluid administration in the setting of burn injury, moni-
toring of efficacy and consensus recommendations are
included in recent work published in the Journal of Burn
Care & Research.[12] Blumetti and coworkers [13] from
the University of Texas Southwestern in Dallas provide a
35 year retrospective and commentary on the present state
of the Parkland formula. This standard for burn resuscita-
tion has recently been critiqued in multiple studies and a
recent editorial review by Saffle pointing out that patients
frequently receive greater amounts of fluid than pre-
dicted.[14] He presents an example of resuscitation excess
from his experience and presents a resuscitation program
incorporating feedback, communication requirements
and clinical targets (Figures 1 and 2). Accuracy and practi-
cality of the Parkland formula are open to question.
Blumetti, et al. conducted a retrospective analysis of burn
patients treated at Parkland Memorial Hospital Burn
Center during a 15 year period from 1991 to 2005.[13]
Included were burns in adults > 19% Total Body Surface
Area (TBSA). In this adult group, adequate fluid resuscita-
tion was defined as a urine output of 0.5 to 1.0 mL/kg/hr.
Over resuscitation was defined as a urine output > 1.0 mL/
kg/hr. In a review of nearly 500 patients, 43% received
adequate resuscitation based on urine output criteria.
Forty-eight percent were over resuscitated. There was no
difference in complication rates or mortality regardless of
over resuscitation versus adequate resuscitation. Patients
were evaluated for inhalation injury with bronchoscopy.
Contrary to reports from other centers, the amount of
fluid required for adequate resuscitation based on target
urine output was not different in patients with inhalation
injury as opposed to those without this insult. While Ivy
and others [15] demonstrated that intraabdominal hyper-
tension and abdominal compartment syndrome com-
monly occurred in burn patients with volume
resuscitation in excess of 250 mL/kg, the Parkland data
reported here notes a 1% incidence of abdominal com-
partment syndrome even in burns exceeding 40% total
body surface area where resuscitation volumes exceeded
250 mL/kg. In summary, even in the home of the Park-
land formula, actual burn resuscitation frequently does
not meet the standard set forth by this clinical strategy.
Patients commonly received higher fluid volumes than
predicted by the Parkland formula. The Parkland team
recommended emphasis on calculated formula volumes
only as a guide to initial resuscitation and the use of care-
ful titration to urine output as the most important inter-
vention.Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 2009, 17:14 http://www.sjtrem.com/content/17/1/14
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Surrogate parameters for adequacy of resuscitation were
discussed in two reports. Jeng and coworkers [16] focused
on wound perfusion as a key factor promoting progres-
sion of burn depth and questioned whether parameters
such as tissue and gastric PCO2 could provide more imme-
diate data on efficiency of resuscitation than measure-
ment of urine output and mean arterial pressure. Four
patients with severe life-threatening burns (median 58%
TBSA) and shock were enrolled in this study. All patients
were adults with percent TBSA burns > 40%. Time
between burn injury and arrival at the burn center was < 2
hours and patients were admitted directly to the burn
center with admission mean arterial pressure < 70 mmHg.
Patients with concomitant electrical injury, trauma or lack
of consent within 24 hours were excluded. Patients were
resuscitated to maintain oxygenation (> 90% saturation),
urine output (30–50 mL/hr) and mean arterial pressure (>
70 mmHg). In these patients with large burns, crystalloid
volumes used in the first 24 hours were very high, averag-
ing 16.8 mL/kg/%TBSA burn, vastly exceeding the Park-
land formula predictions. Even with this massive fluid
administration, cyclic changes were noted in burn wound
pH, PCO2, PaO2, gastric PCO2, gastric PO2, arterial pH
and base deficit. When resuscitation parameters described
above were compared to laser Doppler imaging, a stand-
ard used in this study to evaluate burn perfusion, changes
in gastric PCO2, burn wound pH and burn wound PCO2
mimicked the changes in laser Doppler measured burn
perfusion. Tissue resuscitation parameters showed statisti-
cally significant changes in perfusion 4 hours after the
start of resuscitation while urine output did not change
until 2 hours later. Remarkably, when burn wound per-
Time course of fluid resuscitation for a 6 year-old boy (20 kg) with 33% TBSA scald burns Figure 1
Time course of fluid resuscitation for a 6 year-old boy (20 kg) with 33% TBSA scald burns. He arrived at the burn 
center 6 hours post-injury, having received 900 ml of lactated Ringer's solution prior to arrival. Fluid resuscitation was started 
according to the Parkland forumula (heavy dashed line); nurses were instructed to maintain urine output between 0.9 and 1.8 
ml/kg/h (dotted line). Initial resuscitation was close to Parkland guidelines, but beginning at about 10 hours post-burn, fluid 
requirements increased progressively until about 22 hours post-burn, when urine output finally began to rise, and fluids were 
tapered in a stepwise manner according to protocol. The patient reached his calculated maintenance fluid rate of 106 ml/h at 
hour 36. Total resuscitation received was 11.38 ml/kg/% TBSA. He had no difficulties with compartment syndromes or respira-
tory distress.
J Burn Care Res 2007; 28:382-395
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Protocol for Fluid Resuscitation of the Adult Burn Patient (Begin LR Using Burn Center Fluid Resuscitation Calculations) Figure 2
Protocol for Fluid Resuscitation of the Adult Burn Patient (Begin LR Using Burn Center Fluid Resuscitation 
Calculations). Protocol for fluid resuscitation of adult burn patients. In response to requests from nursing, this protocol was 
developed to permit nursing staff to manage fluid resuscitation of acute burn patients. Initial fluid rates are calculated by the 
Parkland formula. Nurses begin hourly infusion, measure urine output, and adjust fluids according to patient response. Devel-
opment of unstable vital signs, inadequate response to fluids, or persistently high fluid requirements prompt a call to the physi-
cian. A pathway to begin colloid replacement exists for patients who display increasing fluid requirements or develop evidence 
of torso compartment syndrome.
J Burn Care Res 2008; 28:382-395
Reference #14Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 2009, 17:14 http://www.sjtrem.com/content/17/1/14
Page 5 of 13
(page number not for citation purposes)
fusion was improved by interventions based on tissue
parameters, the change did not translate into a measurea-
ble variation in hourly urine output. Use of tissue tonom-
etry at both gastric and burn wound sites provided more
rapid recognition of changes in resuscitation efficacy. It is
important to note that the impact of these interventions
on outcome cannot be demonstrated in this limited data
set.
Batchinsky coworkers [17] at the US Army Institute of Sur-
gical Research with collaboration from the University of
Turku in Finland investigated heart rate variability and its
relationship to cardiovascular regulation after burn injury.
Investigators have noted in other settings of cardiovascu-
lar stress that loss of R to R interval complexity is seen.
These investigators demonstrated abnormally low R to R
interval complexity during early post-burn resuscitation
in a series of 13 patients with mean total body surface area
burn of 36%. All of these patients survived resuscitation.
Progress through resuscitation was associated with
improvement in R to R interval complexity and other evi-
dence of improved end organ support. Nonlinear and fre-
quency domain ECG analysis was employed. These results
mimic those of other investigators studying trauma resus-
citation, particularly the Vanderbilt group.[18]
A consensus statement has also been released from the
American Burn Association regarding burn/shock resuscita-
tion.[12] Notably, no "standards" for the approach to the
resuscitation of burn injured patients exist from contem-
porary data. A number of "guidelines" are supported by
evidence of lesser strength. "Guidelines" and "Options"
from the American Burn Association are listed in Additional
file 1 as published in the Journal of Burn Care &
Research.[12]
Based on the strength of present evidence, there is no con-
sensus regarding optimal fluid composition, rate of fluid
administration and the role of colloid. No resuscitation
parameters specific to individual patient fluid needs are
better than routine hemodynamic endpoints and ade-
quate urine output. Practitioners must be compulsive in
providing adequate fluids but avoiding excessive resusci-
tation in any fluid program employed.
Three additional points of clarification regarding burn
resuscitation should be made. First, many patients, partic-
ularly with burns < 20% TBSA may be candidates for oral
resuscitation as an intact gastrointestinal tract is tolerant
of large amounts of fluid administration. Enteral resusci-
tation should be considered particularly when resources
are limited, an austere setting is encountered, and the
patient is able to tolerate oral intake. Second, invasive
hemodynamic monitors including central venous cathe-
ters and pulmonary artery catheters have been employed
to optimize burn resuscitation in a variety of prospective
and retrospective studies. Patients with invasive central
hemodynamic monitors tended to have far more fluid
administered without improvement in outcome. While
invasive monitoring may be indicated for patients with
special comorbidity or patients who fail to respond to
resuscitation prescriptions, a blanket statement in favor of
this approach cannot be made. Third, antioxidant thera-
pies show promise in reduction of burn resuscitation fluid
requirements and edema formation in a variety of preclin-
ical trials. Unfortunately, patient data is limited and mul-
ticenter prospective validation has not been attempted.
Sepsis and Infection in Burns
In a historic action, the American Burn Association con-
vened a consensus conference on burn sepsis and infec-
tion using methodology recently employed by the Society
of Critical Care Medicine and other critical care societies.
[19-23] The conference and documents produced from it
apply consensus-driven definitions of organ dysfunction
and infection states as described in the general critical care
population and modified these as appropriate to reflect
the perturbation in burn injury. This work is important as
the major cause of late death in the burn patient popula-
tion is multiple organ dysfunction syndrome typically
driven by infection. I will highlight findings of this con-
sensus conference process below.
The concept of Systemic Inflammatory Response Syndrome
(SIRS) should not be applied to burn patients.[20,24] While
this concept is widely accepted and utilized in critical care
practice and clinical trials, it has been widely criticized for
being too inclusive and insufficiently specific to effectively
identify a relevant inflammatory state. Burn patients fre-
quently demonstrate characteristics of SIRS throughout
the majority of hospitalization. Biochemical markers have
also been evaluated but at present do not apply to the spe-
cific physiology of the burn patient.
Sepsis is redefined in the burn patient population.[19] Triggers
in the burn injured patient are different than those in
other critical care populations. As in general critical care
practice, sepsis is a condition warranting empiric antibiot-
ics and a search for infection during that short course of
empiric therapy. Definitions for sepsis in the burn patient
are given in Additional file 2.
The concept of severe sepsis, the intervening state between sepsis
and septic shock was dropped as the conference attendees felt
that as a distinct state between sepsis and septic shock,
severe sepsis is not regularly seen. Septic shock definitions
from recent consensus conferences including the Surviv-
ing Sepsis Campaign and consensus work of the major
critical care societies are retained.[25]
Septic shock is defined as sepsis-induced hypotension per-
sisting despite adequate fluid resuscitation. Sepsis-Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 2009, 17:14 http://www.sjtrem.com/content/17/1/14
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induced hypotension is defined as a systolic blood pres-
sure (SBP) < 90 mmHg or mean arterial pressure < 70
mmHg or a SBP decrease > 40 mmHg or < 2 SD below
normal for age in the absence of other causes of hypoten-
sion. Sepsis-induced tissue hypoperfusion is defined as
septic shock, an elevated lactate or oliguria.[25]
Smoke inhalation injury by anatomic definition occurs
below the glottis and is caused by products of combus-
tion. Diagnosis requires history of exposure to products of
combustion and bronchoscopy revealing carbonaceous
material or signs of edema/ulceration. Smoke inhalation
injury can occur with or without detection of products
such as cyanide or carbon monoxide. Anatomic injury,
however, is the hallmark of smoke inhalation injury.
Bronchoscopy is the "gold standard" for diagnosis.
Pneumonia, a common complication of inhalation injury,
is defined similar to previous consensus conferences by
critical care and respiratory societies.[26,27] The ABA
Consensus Group did make statements regarding positive
microbiology. Greater than 105 organisms on a tracheal
aspirate, bronchoalveolar lavage with ≥ 104 organisms
and protected bronchial brushings with > 103 organisms
are general criteria for positive microbiology in the setting
of burn injury. The burn literature supports discontinua-
tion of antibiotics where microbiologic thresholds are not
met. The Clinical Pulmonary Infection Score was briefly
discussed and felt to be insufficient to predict ventilator-
associated pneumonia in the burn victim. Clinical suspi-
cion of ventilator-associated pneumonia must be verified
by quantitative culture results.
Definitions for bloodstream and catheter-related blood-
streams infections are accepted as defined previ-
ously.[28,29] Catheter colonization is seen where growth
of organisms from a catheter segment is identified by sem-
iquantitative or quantitative culture. A catheter-related
bloodstream infection reflects identification of the identi-
cal organism in a blood culture and a semiquantitative or
quantitative culture from a catheter segment. Clinical
symptoms of bloodstream infection should also be
present without any other apparent source of infection.
Finally, exit site infection is defined as erythema, tender-
ness, induration or purulence within 2 cm of the exit site
of a catheter. Blood cultures should ideally include quan-
titative technique with a specimen of ≥ 10 ml. Blood cul-
tures must also reflect recognized pathogens not usually
regarded as skin contaminants cultured from one or more
blood cultures. An organism cultured from the blood to
reflect a primary bloodstream infection is not related to
infection at another site.
Definitions of wound-related complications were also
assembled. [30-32]Wound colonization is present with
bacteria on the wound surface at low concentrations.
Wound infection is present with high concentrations of
bacteria in the wound and wound eschar (> 105 bacteria/
gram tissue). Invasive infection occurs with high concen-
tration of pathogens (> 105 bacteria/gram tissue) and
changes such as separation of eschar or skin grafts, inva-
sion of adjacent unburned tissue or development of sepsis
as defined above. Cellulitis is seen with bacteria in the
wound or wound eschar at high concentrations and
advancing erythema, induration, warmth and tenderness
of surrounding tissues. Sepsis, as defined above, must be
present.  Necrotizing fasciitis is an aggressive, invasive
infection with necrosis of tissues beneath the skin. Among
objective diagnostic criteria are biopsy and swab culture
techniques. None of these are ideal. Clinical correlates
include systemic changes, premature separation of eschar
and unexplained tissue loss or changes in the depth of
wounds. Pseudomonas aeruginosa is a frequent colonizing
organism in burn and other soft tissue wounds. The yel-
low/green exudate of pseudomonas does not reflect inva-
sive infection. When changes consistent with deep tissue
injury and systemic changes including organ dysfunction
are seen, aggressive antibiotic therapy and surgical debri-
dement are warranted.[19]
This rich document summarizes much of the contempo-
rary thinking on infectious complications in the setting of
burns and soft tissue injury. The authors hope that this
standardization of reporting for infectious complications
and associated organ dysfunction with burn injury leads
to improved study design and evolution of new therapies
for these patients.
Obesity
Two papers examine the impact of obesity on disability
after burn injury and mortality related to this form of
trauma. In the first paper, Carpenter and coworkers [33]
review the National Burn Registry from 2000 to 2006. This
review included over 100,000 patients. These investiga-
tors stratified patients by their identification as obese or
non-obese in the Registry. Two outcome measures exam-
ined were length of stay (< 7 days or ≥ 7 days) and mortal-
ity. Obese patients were far more likely to have to have a
length of stay > 7 days and to die following burn admis-
sion. Of factors gathered in the Registry, obesity was more
than 4 times as likely to be associated with length of stay
7 days or greater (p < 0.0001). In terms of magnitude of
impact on length of stay, obesity is similar to coronary
artery disease, hypertension and alcohol abuse as a risk
factor for length of stay 7 days or more. Obesity increased
mortality 2.6-fold in this large data sample (p = 0.001).
The impact of obesity on mortality was similar to that of
coronary artery disease and hypertension. With respect to
length of stay and mortality, pneumonia was a more pow-Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 2009, 17:14 http://www.sjtrem.com/content/17/1/14
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erful predictor than obesity and the other factors dis-
cussed.
Obesity is common in the United States. Literature cited
by these authors notes that 32% of the American popula-
tion may now be considered to be obese compared with
20% one decade ago. [34-37] Remarkably, in this data set,
the total number of patients indicated as obese is only 672
out of over 100,000 entries. Thus, a significant under rep-
resentation and biased representation of obesity is possi-
ble in the National Burn Registry. The burn size and
characteristics in obese as opposed to non-obese patients
are not discussed. While I do not argue with the impact of
obesity on outcomes in burn injury as presented here, it is
clear that a stronger emphasis on population of data fields
related to nutrition status will enhance the power of the
National Burn Registry to effectively evaluate the impact of
obesity on burn outcomes.
Farrell and coworkers [38] from the Loyola Burn Center
examined the impact of obesity on functional outcomes
in a more tightly characterized acute burn population.
Recognizing that factors other than body mass index may
affect discharge disposition in patients with burn injury,
these investigators evaluated the impact of age, TBSA
burn, inhalation injury and Body Mass Index (BMI) on
discharge disposition. This study was much smaller than
that previously reported with only 221 patients age 16 or
older. However, the consistency of recording is greater
than the massive database of the National Burn Registry.
The Loyola investigators recorded not only metabolic data
but also Functional Independence Measure (FIM) scores
for patients evaluated.
Using a Classification and Regression Tree (CART), non-
parametric analysis methodology, these investigators
found that the strongest predictor of discharge disposition
was TBSA burn. Over 80% of patients with < 30.75% TBSA
burns returned directly home after hospitalization. Only
27.6% of patients with > 30.75% TBSA burns were dis-
charged to home. In patients with < 30.75% TBSA burns,
age also predicted discharge disposition. Patients younger
than 57.5 years were more likely to go home (90%) com-
pared with patients older than 57.5 years (47.5%). In
patients older than 57.5 years with < 30.75% TBSA burns,
BMI has a role in predicting discharge disposition. In this
population, BMI > 27.4 suggested decreased likelihood to
return home (21.4%) while patients with a lower BMI (<
27.4) were more likely to return home (65%). Age, inha-
lation injury and BMI did not have a role in predicting dis-
charge in patients with larger burns.
Particular attention was paid to Functional Independence
Measure (FIM) transfer scores. The strongest predictor of
FIM transfer scores was the size of the burn. Patients with
< 22.5% TBSA burns had a higher FIM score than patients
with > 22.5% TBSA burns. In older patients with smaller
burns, BMI was a factor. Patients with a BMI < 31.25 had
a higher average FIM score than larger patients.
The CART regression model used by the Loyola team is a
tool permitting clinicians to determine variables contrib-
uting to patient outcome in the face of specific patient
characteristics. Not surprisingly, size of injury was the
strongest predictor of outcome. [39-41] However, in
larger burns, female gender also predicts poorer outcome
than males. Older patients with smaller burns most
acutely feel the impact of obesity where reduced function
is noted in the larger patient. Finally, this work confirms
the adverse effect of increasing age on functional out-
comes after burns.
While 221 subjects is significant given the number of data
points collected, many of the individual comparisons in
this multiple regression technique contain small numbers
of patients. Insurance and other social status concerns
could also affect disposition at discharge. These potential
sources of bias cannot be eliminated in this retrospective
work.
Pulmonary Injury
Respiratory failure in burns is generally characterized by
hypoxemia with evolution to Acute Lung Injury or Acute
Respiratory Distress Syndrome (ARDS).[42] Even in
patients without defined inhalation injury, the presence
of ARDS is associated with poorer outcome. Where smoke
inhalation and ARDS are combined, in the pediatric pop-
ulation a mortality in excess of 50% is noted.[43] While
there is no consensus regarding the optimal ventilatory
strategy, two recent papers discuss potential adjuvant ther-
apies. A report from the Cincinnati Shriners Hospital for
Children evaluates an anti-inflammatory pulmonary
enteral nutrition formula which has been previously used
in adults.[43] This is a retrospective review examining
patients receiving a specialized enteral formula in the set-
ting of respiratory failure after burn injury. Mean age of
this patient group was approximately 5 years. Patients
included had a PaO2/FiO2 ratio of < 200 mmHg at the
time of specialized nutrition support. Median burn size
was 36% TBSA with 24% TBSA full thickness. Seventeen
of 19 patients ultimately survived. In some cases, multiple
tube thoracostomies and advanced ventilator support
were required. In addition to improvements seen in respi-
ratory function parameters, chemistries including BUN,
creatinine, sodium and potassium also improved with
administration of the specialized nutrition support pro-
gram. This limited retrospective data set is presented to
support further evaluation of specialized nutrition sup-
port for burn injured patients.
There is a clear physiologic rationale for the specific nutri-
tion intervention provided.[43,44] The formula testedScandinavian Journal of Trauma, Resuscitation and Emergency Medicine 2009, 17:14 http://www.sjtrem.com/content/17/1/14
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provides a high quantity of protein and moderately low
carbohydrates.[45] Eicosapentaenoic acid, gamma-lino-
lenic acid and antioxidants are added for anti-inflamma-
tory properties and to oppose the tendency toward
oxidative stress in the burn injured patient with lung
injury. [46-49] Elsewhere in the critical care literature,
however, there has been a movement away from immu-
nonutrition due to inability to predict, in a consistent
way, the appropriate timing for proinflammatory or anti-
inflammatory interventions.[50] Clearly, in this retrospec-
tive database, many interventions, particularly ventilator
strategies which could affect the outcome of lung injury in
burn injured patients, are not discussed. Perhaps most
important, we lack a consistent understanding of the
physiology of inflammation in lung injury and how to
assess the inflammatory state of a patient when this anti-
inflammatory material is given. Caution is advised.
Holt and coworkers [51] from the University of Utah
examined another adjuvant therapy for inhalation injury,
a combination protocol of inhaled heparin/N-acetylcys-
tine. Again, a retrospective database was employed. Sixty-
two of 150 patients admitted with inhalation injury from
1999 to 2005 were reviewed. Inhalation injury was based
on confirmatory bronchoscopy, clinical suspicion or ele-
vated levels of carboxyhemoglobin. The authors do not
indicate the proportional use of each diagnostic criteria.
Demographic and pulmonary data were reviewed.
The heparin/N-acetylcystine protocol utilized at this burn
center was initiated at the time of admission but at the
attending physician's discretion. Patients placed on this
protocol received inhaled heparin (5000 U/l mL), N-ace-
tylcystine (3 mL of 20% solution) and albuterol (2.5 mg
of 0.083% solution per 3 mL) every 4 hours for the first 7
days after admission or until extubation. No difference in
key physiologic or clinical outcomes was noted. The
authors do report better PaO2 on day #1 and day #3 of the
heparin/N-acetylcystine protocol compared to patients
who did not receive these medications. By 72 hours, this
difference had disappeared. Overall, mortality, incidence
of pneumonia and resource consumption was not
affected.
Management of inhalation injury consists of supportive
care. This may include mechanical ventilation with sup-
plemental oxygen therapy and pulmonary toilet either
through catheter means or bronchoscopic interventions.
Herndon and the Galveston group have investigated in
preclinical and clinical material the impact of strategies to
reduce inflammation and free radical formation with
combinations of heparin/N-acetylcystine. [52-55] The
Utah group was unable to replicate the success of the
Galveston program with inhaled heparin/N-acetylcystine
for reasons which remain unclear. It should be noted that
the data reported by the Galveston group favoring the use
of heparin/N-acetylcystine came from a pediatric patient
population where the Utah group studied both adults and
children. In addition, the Utah data is retrospective and in
the discussion, writers admit that not all chart data was
complete. At best, we are left with a call for additional pro-
spective, multicenter data evaluating anti-inflammatory
strategies in the setting of lung injury and smoke inhala-
tion.
Outcomes
For over half a century, investigators have sought predic-
tive indices for outcomes in burn injury. Perhaps the best
known is the Baux rule, a simple sum of patient age and
total body surface area suffering 2nd  and 3rd  degree
burns.[56] This index has been and continues to receive
attention. In fact, the Baux rule was recently addressed
using patient registry data from the American Burn Associ-
ation.[57]
Two more recent articles detail burn outcome. The more
recent comes from the National Burn Repository which
published a 10 year review in 2006.[58] In all, over
125,000 acute burn admissions to United States' burn
centers were described. Seventy percent of hospital admis-
sions were male (mean age 33 years). Infants accounted
for 10% of cases and patients aged ≥ 70 years comprised
8.5% of cases. Thirty-two percent of admissions were < 20
years old. Sixty percent of patients were 5 to 50 years olds.
Sixty-two percent of patients had a total burn size of <
10% of total body surface area with 21% having burn size
between 10–19.9% of the total body surface area. Only
10% of patients had burn size > 30% total body surface
area. Inhalation injury was reported in 6.5% of patients.
In patients sustaining inhalation injury, mortality was
30% as opposed to 5% for the patient group as a whole.
Thus, inhalation injury has a disproportionate effect on
mortality following burns.
Flame and scald burns accounted for 78% of total cases
with the largest fraction of injuries occurring in the home
(43%).[58] Work-related injuries comprised 17% of all
cases. Survival in the overall study cohort has remained at
approximately 95%. Deaths from burn injury increased
with advanced age and burn size and in the presence of
inhalation injury. The leading cause of death was multiple
organ failure. Most frequent complications were pneumo-
nia, wound infection and cellulitis. During the 10 year
period from 1995 to 2005, the average length of stay
declined from 13 to 8 days.
A second review of over 1600 patients admitted to the
Massachusetts General Hospital and the Schriners' Burn
Institute in Boston was published in early 1998.[59]
Logistic regression analysis was employed to developScandinavian Journal of Trauma, Resuscitation and Emergency Medicine 2009, 17:14 http://www.sjtrem.com/content/17/1/14
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probability estimates for mortality based on a small set of
well-defined variables. Mean burn size and survival were
similar to the larger report above. Three risk factors for
death were identified: age > 60 years; total body surface
area burn > 40% and inhalation injury. The mortality for-
mula developed from these reports predicts 0.3%, 3%,
33% or 90% mortality depending on whether 0, 1, 2 or 3
risk factors are present respectively.
A more recent report from a Canadian regional burn
center was recently published in the Journal of Trauma.[60]
An accompanying report also appears in the Journal of
Burn Care and Research.[61] The Canadian investigators
proposed predictors including characteristics of the burn
and APACHE II Score as predictive prediction of outcome.
The score coined by these investigators (FLAMES) was
derived in a population seen between 1991 and 1995 and
validated in a larger population treated between 1995 and
2003. The FLAMES Score including fatality by longevity,
APACHE II Score, gender and extent of burn had an excel-
lent receiver operating characteristic curve of 0.97. Com-
parable results were obtained in the development and
validation populations. Two interesting observations can
be made from this data. First, inhalation injury had no
impact on outcome. In fact, the number of patients with
documented inhalation injury is exceedingly small. In this
respect, this dataset is unlike that seen in American burn
centers[60]. A second observation stems from a report
published by the same investigators about improvement
in survival over time in patients treated at the same burn
center.[61] Thus, consistency in clinical practice may not
have been present during the interval of this work. Finally,
I note that the APACHE II Score, as employed by these
investigators, was developed in a population which did
not include burn patients.
Mustonen and Vuola [62] from Helsinki review burn ICU
outcomes with acute renal failure in a population of over
1300 patients admitted between November 1988 and
December 2001. These authors used a liberal definition of
"acute renal failure", defining it as a rise in serum creatinine
of > 120 μmol/l (1.4 mg/dl) or a two-fold rise in creati-
nine by more than 100 μmol/l (1.1 mg/dl) during one
day. These authors were very aggressive with initiation of
renal replacement therapy. They began renal replacement
therapy with serum creatinine > 180 μmol/l (2 mg/dl),
urea > 30 μmol/l, anasarca or pulmonary edema without
response to diuretics. Of 238 patients admitted to the
intensive care unit, 39% suffered some form of renal
injury as defined above and 13.4% of patients required
renal replacement therapy. Examined in the burn popula-
tion as a whole, 2.3% of patients required renal replace-
ment therapy.
After stratifying patients based on presence or absence of
acute renal failure, the authors note that mortality of
patients without renal failure was 6.9% but that of
patients with renal failure was 44.1%. In the more severely
affected population, those patients receiving renal
replacement therapy, mortality was 62.5%. Not surpris-
ingly, burn size was significantly larger in patients with
acute renal failure (40.2%) than in patients without acute
renal failure (25.7%). Consistent with the critical care lit-
erature in general, if the patient survives in ICU, kidney
recovery occurs. Only one patient in this series had to con-
tinue intermittent hemodialysis after discharge from the
hospital. None of the patients who survived after acute
renal failure with renal replacement therapy required dial-
ysis at one year.
The Helsinki data is consistent with the broader critical
care literature in that mortality associated with acute renal
insufficiency, particularly if dialysis is required, is 50–
60%. [63-65] If patients survive hospitalization, renal
insufficiency tends to resolve, though biochemical abnor-
mality may remain. The low overall incidence of renal
insufficiency in this population reflects the effectiveness
of the Parkland formula-based resuscitation utilized by
these practitioners. Though infrequent, rhabodomyolysis
predicted poor outcome in these patients.[66]
Toxic Epidermal Necrolysis (TEN), originally described in
the 1950s is now a growing part of burn center prac-
tice.[67] While pathogenesis remains unclear, TEN is
thought to be one of a continuum of disorders associated
with epidermal detachment associated with inflamma-
tion and denudation of mucosal surfaces.[68,69] The
most common trigger for TEN is thought to be drug expo-
sure with anticonvulsants, sulfa drugs and allopurinol the
frequently implicated agents. Other disorders in the series
of cutaneous drug reaction syndromes include Stevens
Johnson Syndrome which is the mildest manifestation of
this group of disorders and the intermediate severity state
of Stevens Johnson Syndrome-Toxic Epidermal Necrolysis
(SJS-TEN). These forms of illness are distinguished by
extent of epidermal detachment involving > 30%, 10–
30% or < 10% of the TBSA in TEN, SJS-TEN and SJS. Out-
come appears to vary according to diagnosis (and TBSA
involvement). Mortality in TEN is approximately 30%
while that of SJS is < 5%. The primary cause of death is
infection and multiorgan failure. The likelihood of devel-
oping TEN is significantly higher in patients with HIV
related disorders than the normal population.[68,69]
General treatment begins with withdrawal of any offend-
ing drug.[68] Medication intake for up to a month prior
to the onset of symptoms must be examined for potential
offending agents. Skin care involves removal of nonviable
epidermis and some form of coverage. Some authors rec-
ommend the use of biologic dressings including cryopers-
erved cutaneous allografts, porcine zenografts, collagen-
based substitutes or amnion-based prostheses. Others useScandinavian Journal of Trauma, Resuscitation and Emergency Medicine 2009, 17:14 http://www.sjtrem.com/content/17/1/14
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the involved native epidermis as a biologic dressing with
replacement dressings only on exposed dermis. The liter-
ature holds no consensus regarding the value of early
removal of involved epidermis. Ocular involvement
requires topical lubrication, steroid drops and release of
symblepharon.
Outcome is predicted by the SCORTEN system which uses
variables present during the first 24 hours after admission
to estimate the severity of TEN and predict mortal-
ity.[70,71] Originally described in a series of patients with
cutaneous disorders ranging from SJS to TEN, SCORTEN
gives each risk factor a score of 1 and utilizes the sum of
these values so that a higher score is associated with
greater mortality. SCORTEN is based on a logistic regres-
sion study deriving a predictive death equation. The figure
and table below indicate the SCORTEN risk variables and
outcomes. Each variable is one SCORTEN point. (Figure 3
and Additional file 3)
The Ross Tilley Burn Centre recently evaluated the
SCORTEN system in a consecutive series of patients
admitted between April 5, 1995 and June 10, 2006.[70]
Good correlation between actual outcomes and predicted
mortality from the SCORTEN relationship was identified.
This is remarkable given the significant amount of time
over which these cases were collected. Another recent
study involved 144 patients treated between 1993 and
2003 where SCORTEN was calculated daily during the
first 5 days of admission.[72] The discrimative power of
SCORTEN improved with repeated calculation. Thus,
SCORTEN may be even more accurate if calculated in a
serial fashion rather than basing it on variables present on
the first day of hospitalization, as originally described.
A number of treatment strategies for TEN have been pro-
posed.[68,73] However, given the infrequent presenta-
tion of these patients, randomized, prospective data is rare
and multicenter trials may ultimately be required to pro-
vide consensus-driven treatment strategies. The lack of
definitive understanding of the pathology of TEN also
hampers therapies based on an understanding of mecha-
nisms of disease.
Another dimension of practice in many burn centers is
management of complex wounds including soft tissue
infections. Saffle and coworkers [74] from the University
of Utah investigate the outcome associated with
Fournier's gangrene, a necrotizing infection associated
with genitalia, perineum or perianal tissues. While burn
centers frequently care for these patients, Saffle and cow-
orkers compared burn center results to those obtained in
other settings. [74-77]
A review of charts took place at the Utah Burn Center from
1992 to 1995 and identified 30 patients with complex
perineal infections. Among demographic data, male gen-
der (67%), the presence of diabetes and referral from out-
side hospitals were common. Many of these patients were
morbidly obese and used systemic immunosuppressing
agents including corticosteroids. Liver disease and renal
insufficiency were also common. Standard of care was ini-
tial operative debridement within 24 hours of admission.
Patients were subsequently returned to the operating
room every 2 to 3 days until debridement was complete
and remaining tissue appeared viable. Burn dressings with
topical antibiotics were employed to compliment sys-
temic antimicrobial therapy. Skin grafting or local tissue
flaps were commonly used for wound closure. Patients
required a mean of 4.1 surgical procedures. Definitive
wound closure was obtained in 72% of patients prior to
discharge. Patients with open wounds were treated with
negative pressure dressings or wound packing until sec-
ondary healing occurred. Mean length of hospitalization
was 25 days. Consistent with other reports, five patients
died in this series for a mortality of 16.6%.[78] Hyper-
baric oxygen was not available in this center and not
employed in management of this series of patients.[79]
There is a wide range of mortality reported for complex
perineal infections in the literature. Due to the uncom-
mon nature of this presentation, large data sets do not
exist. The role of hyperbaric oxygen remains unclear but
this dataset suggests that aggressive surgery, broad organ
system report and antibiotic therapy provide equivalent
outcomes where hyperbaric oxygen is not available.[79]
SCORTEN Mortality and Risk Variables Figure 3
SCORTEN Mortality and Risk Variables.
P (death) = e
logit / 1 + e
logit
[where logit = 4.448 + 1.237 (SCORTEN)] 
SCORTEN= number of risk factors from list below:
Age >40 years 
Presence of malignancy 
% TBSA of detached epidermis >10% 
Heart rate >20 beats/min 
Blood urea nitrogen (BUN) >28 mg/dl (>10 mmol/L)
Serum glucose >252 mg/dl (>14 mmol/L) 
Serum bicarbonate <20 mEq/L 
Modified from J Burn Care Res 2008; 29:142
Reference #70Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 2009, 17:14 http://www.sjtrem.com/content/17/1/14
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Further, these authors note that diverting procedures
including suprapubic cystostomy, colostomy and orchiec-
tomy are generally not required and that burn centers can
provide adequate reconstruction for these complex prob-
lems.
Development of burn centers in the United States has
been associated with a verification process to standardize
and optimize overall quality of care delivered.[80,81]
Burn centers have been demonstrated to improve survival
and decrease resource consumption. Palmieri and cow-
orkers [80] examined the difference in outcomes between
burn centers receiving verification from the American Burn
Association and the American College of Surgeons as opposed
to burn centers which were not verified. Using the dis-
charge database from the state of California, 5 verified
burn centers were compared with 12 non-verified burn
centers. In 2003, 2867 patients were admitted to burn
centers; over 1600 of these patients were admitted to non-
verified centers. Non-verified centers admitted 132
patients per center while verified centers admitted 244
patients per center. Verified centers admitted more
patients with large burns, burns requiring complex recon-
struction and more patients requiring critical care support
including mechanical ventilation. Verified burn centers
also performed fewer operations than non-verified cent-
ers. More patients from verified centers were able to return
home while additional rehabilitation care was required in
patients from non-verified centers. Mortality, however,
was 3% in non-verified burn centers and 4% in verified
burn centers.
While the lack of difference between morality in verified
and non-verified burn centers is encouraging, significant
differences in resource consumption including operative
procedures, post-discharge destination and median hos-
pital charge support the use of verified burn centers in the
management of burn-injured patients. Clearly, the popu-
lation seen in verified and non-verified burn centers is dif-
ferent and this report details resource consumption issues
which may be better addressed in a regionalized burn care
system.[82,83]
Conclusion
￿ The burn patient is easily over resuscitated. Practitioners
must be willing to reduce fluid prescriptions when signs
of adequate perfusion are present. Currently, adequate
vital signs and urine output are the "gold standard" for per-
fusion assessment.
￿ The burn-injured patient does not fit traditional defini-
tions of Systemic Inflammatory Response Syndrome
(SIRS) and sepsis must be redefined based on the physio-
logic characteristics of burn injury. In addition, the burn
patient is at risk for soft tissue infections and burn wound
infection which have been better defined.
￿ Obesity is a marker for increased resource consumption
in the setting of burn injury. Impact of obesity on mortal-
ity is similar to that of coronary artery disease and hyper-
tension.
￿ "Gold standard" therapy for inhalation injury remains
lung protective mechanical ventilation. Specialized nutri-
tion and medical therapies have been evaluated but wide-
spread consensus regarding their value is absent.
￿ A number of factors are predictive of mortality in burn
injury. Burn size, presence or absence of inhalation injury
and extremes of age have been previously reported.
￿ Renal failure and insufficiency is a marker for poor out-
come following burn injury.
￿ Support for use of burn centers in management of soft
tissue problems outside traditional burn injuries such as
Toxic Epidermal Necrolysis and soft tissue infections can
be obtained from recent papers.
￿ Use of verified burn centers reduces cost of therapy for
burn injury.
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